Please provide your email address to receive an email when new articles are posted on . Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results